产前外显子组测序评估胎儿先天畸形的临床效用证据:科学影响论文第64号
本文综述产前外显子组测序(ES)在超声发现胎儿结构异常但标准染色体检测阴性时的诊断价值。近期两项研究显示,此类病例中ES可额外发现至少10%的遗传学诊断。文章为临床实践提供指导,并讨论结果解读等挑战。
要点
- 超声发现胎儿结构异常时,标准染色体检测仅能揭示约40%的潜在病因。
- 标准染色体检测阴性后,产前ES可额外发现至少10%的遗传学诊断。
- ES结果可能意义不明,需结合父母DNA检测并谨慎解读。
核心结论
- 产前ES可提高结构异常胎儿的遗传学诊断率,但存在结果解读挑战。
研究设计与样本
- 本文为科学影响论文,综述近期两项研究及更早的ES证据。
主要发现
- 标准染色体检测仅能揭示约40%结构异常胎儿的潜在病因。
- 近期两项研究显示,标准染色体检测阴性时产前ES可发现至少10%的遗传学诊断。
关键数值与推荐
- 超声发现结构异常时,通常提供绒毛膜绒毛取样或羊膜腔穿刺进行遗传检测。
- 产前ES需结合父母双方DNA检测以协助解读胎儿遗传改变。
临床怎么用
- 对超声结构异常且标准染色体检测阴性的胎儿,可考虑产前ES以明确诊断。
- ES结果可为父母妊娠决策及医生母婴管理提供信息,并评估再发风险。
局限性
- 产前ES可能无法找到遗传学解释。
- 部分遗传改变对妊娠的意义不明确,结果解读困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Structural differences (congenital anomalies) in the makeup of the baby's heart, brain and other organs are found on antenatal ultrasound scans in up to 3% of pregnancies. These often have a genetic cause, arising because of changes in the chromosomes (which store our genetic material) or the DNA code that make up the genes. The more differences a baby has the more likely the risk of underlying genetic disease. If a structural difference is found, parents are usually offered a genetic test, which may be carried out on cells taken either from the placenta (chorionic villous sampling) or the fluid surrounding the baby (amniocentesis). At the moment, these cells are only tested for changes in the chromosomes and are only able to reveal the underlying cause in about 40% of unborn babies. Prenatal exome sequencing (ES) is a new genetic test, which, when combined with testing the DNA of both parents can find changes in the baby's genetic code. If a DNA change is found that can explain the structural changes seen on ultrasound, specific information about the underlying diagnosis can be given to the parents. Having this information can help parents make important decisions about their ongoing pregnancy, as well as help doctors to care for the mother and baby. Finding a genetic change can also help to understand how the condition has arisen and whether it might happen again in another pregnancy. It may also be possible to test for the genetic condition in future pregnancies. Although prenatal ES is an exciting new way to improve diagnosis rates for structural differences, it has some challenges. While the test is very detailed, it may not always find a genetic explanation and sometimes the results are difficult to interpret. For example, genetic changes can be found where their significance for the pregnancy is unclear. More recently, two studies have now shown that prenatal ES can find a genetic diagnosis in at least 10% of pregnancies with structural differences where standard chromosome testing has been negative. This paper reviews these studies, along with earlier evidence on ES and provides clinicians with guidance for future practice.
引用
- Mone F, McMullan DJ, Williams D, et al. Evidence to Support the Clinical Utility of Prenatal Exome Sequencing in Evaluation of the Fetus with Congenital Anomalies: Scientific Impact Paper No. 64 [February] 2021. BJOG. 2021. PMID: 33590639. doi:10.1111/1471-0528.16616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。